We recommend a 'Strong Buy' rating for Alcon with a $118 price target, citing new product launches and steady growth in ...

Alcon, the global eyecare company with manufacturing and research facilities in Berks County, reported third quarter results ...

Analyst Jeff Johnson of Robert W. Baird maintained a Buy rating on Alcon (ALC – Research Report), retaining the price target of $110.00.

Alcon Inc (ALC) reports strong international growth and prepares for new product launches despite facing competitive pressures in the US market.

The annual China International Import Expo (CIIE) taking place in Shanghai serves as a prime platform for foreign companies to showcase innovations, breakthrough technologies, and quality products; ...

1,3-4* “We are making history with the bold innovation of PRECISION7,” said Max Wolf, General Manager, Head of Vision Care and Contact Lenses at Alcon. “Now, patients can start and end every ...

Alcon, Inc. ALC delivered core earnings per share (EPS) of 81 cents for the third quarter of 2024, up 22.7% from the year-ago ...

Yesterday, Alcon was alerted that our third quarter earnings press ... I’m also excited to announce that we’ve completed the migration of all of our intraocular lenses, including PanOptix, Vivity, and ...

11**† Alcon will highlight new data on its industry-leading surgical products. A selection of studies to be presented at AAO include: “Comparing the effects of two different intraocular ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of PRECISION7®, the only one-week replacement contact lens with ...